G-CSF

Quick Detail

Package & Delivery Lead Time

Detailed Description

G-CSF Generic name: Recombinant Human Granulocyte Colony-stimulating Factor Injection; Indication: 1. indicated for neutropenia induced by cancer chemotherapy. After cancer patients are treated with marrow-inhibited chemotherapeutic drugs， particularly with strong marrow-deprived chemical drugs, administration of this product is helpful to prevent neutropenia from occurring, to reduce the level of neutropenia， to shorten duration of agranulocytosis， to accelerate recovery of granulocyte，and therefore to reduce danger of infection complicated with fever; 2. to promote increase of neutrophil count after marrow transplantation； 3. indicated for neutropenia induced by myelodysplastic syndrome, for neutropenia induced by aplastic anemia, for congenital and acquired neutropenia, for neutropenia accompanied by myelodysplastic syndrome, and for periodical neutropenia; Specification: 75μg/0.3ml/vial, 100μg/0.4ml/vial, 125μg/0.5ml/vial, 150μg/0.6ml/vial, 200μg/0.8ml/vial, 300μg/1.2ml/vial; Storage: store at 2~8 ℃, protect from light and prohibit from freezing; Shelf period: 24 months;

Basic Company Information

Shenzhen Xinpeng Bio-tech Co., Ltd

Company Advantage

Detail Company Introduction